disorders of clotting Flashcards

1
Q

what is cocktail purpura

A

happens in people who drink gin and tonic
tonic water has quinine which causes platelts to clump and be removed from the body
-petechiae may show up the next day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the normal PT

A

10-13 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PT prolonged with what deficicny and what drug

A

factors II, V, VII, X and fibrinogen

warfarin or dicoumarol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

normal PTT time

A

25-40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PTT prolonged in what deficiency and what drug

A

factors VIII, IX, XI, XII

heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does Thrombin time (TT) assess for

A

deficiency or abnormalities of fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

most common qualitative platetelet defect

A

in pts taken aspirin or NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treatment of DIC

A

correction of underlynig disorder- sepsis, bowel obstruction etc

supporive care- platelet and factor replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

thrombotic thrombocytopenic purpura

add one more symptom and it gives you what

A

characterized by purpura, microangiopathic hemolytic anemia, fluctuating neurological signs, renal dysfunction and febrility anad thrombocytoenia under 50,000

add renal failure = HUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

helmet cells known as waring blender effect

A

TTP

-hyaline thrombi occlude capillaries of virtually every organ in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cause of acquired TTP

A

autoantibodies directed at ADAMTS13

linked to infection, malignancy, immune disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

treatment for TTP

A

plasmapheresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

treatment for VWD

A

cryoprecipitate –>replaces vWF
DDAVP–> causes relase of vWF from endothelium
antifibrinolytic agents like aminocaproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PT with deficiency of vitamin K dep factors

A

prolonged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hereditary hemorrhagic telangiectasia

A

only endothelial syndrome associated with hemostatic complications
-caused by thinning of vessel walls with telangiectatic formations, AV malformations, and aneurysmal dilations throughout the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HHT inheritence and defect

A

autosomal dominant

defect in gene coding for endoglin on chrom 9

17
Q

clinical features of HHT

A

telangiectasis on tip of tongue and lip mainly
bleeding to mild or inapparent trauma
-epistaxis is the most frequent symptom

18
Q

course and treatment of HHT

A

usually benign clinical course, recurrent bleeds frequent but death rare

surgery and laser photoablation of telangiectasias of some value but care must be used in selecting site

19
Q

antithrombin III deficiency clinical presentation

A

variable from minimal symptomatology to early death from recurrent pulmonary emboli
50% of affected pts have DVT and or PE by age 30

20
Q

AT III diagnosis

A

less than 50% of normal activity of AT III levels in serum

21
Q

treatment for AT III deficiency

A

prophylactic treatment with anticoags
pts with DVT need heparin but much higher doses required
AT III replacement therapy is available for known deficient pts

22
Q

protein C and S function

A

S is cofactor for C which inactivates V, and VIII

23
Q

what do you give pts with protein C and S deficiency

A

warfarin to decrease the risk of thromboembolic disaeae

-beware that warfarin can also suppress these factors causing a hypercoagulable state

24
Q

factor V leiden and treatment

A

abnormalitiy of factor V at binding site for activated protein C

no prior DVT just moniter
prior episodes then consider lifelong anticoagulation

25
Q

prothrombin 20210

A

increaed activity for prothrombin bc of mutation so it isn’t deactivated
risk of thrombosis is high
-same treatment as factor V

26
Q

antiphospholipid syndrome

A

aka anticardiolipin antibody syndrome
lupus anticoagulant
false postivtve VDRL antibody syndrome

27
Q

clincial clues suggesting an inherited hypercoagulable disorder

A

thrombosis at young age under 50
multiple thromboses episodes
thrombosis in an unusual site
family history of thrombosis

28
Q

characterized by venous and arterial thrombsois
recurrent spontaneuous pregnancy loss
thrombocytopenia
neuropsychiatric manifestaions

A

antiphospholipid antibody syndrome

29
Q

what events most common in antiphospholipid antibody syndrome
how to treat

A

cerebrovascular events most common arterial thrombotic complication with stroke and TIA and dementia of retinal artery occlusion
placental vessel thrombosis leads to pregnacny loss and fetal growth retardation
-treat with warfarin

30
Q

what causes false postitive VDRL antibody syndrome

A

antiphos syndrome when testing for neurosyphillis

31
Q

associated features of APS

A

CT disease
prolonged PTT, fails to correct with mixing
valvular heart disease in some
coronary artery disease

32
Q

diagnosis; 3 test APS

A

prolonged PTT
lack of correction in mixing
neutralization of inhibitor with excess phospholipid

33
Q

confiramtion test APS

A

DRVVT

34
Q

treatment for APS

diagnosis confirmation

A

those with history of thromboembolic disease: lifelong anticoagulation
need multiple postiive tests over 3-12 month period to make diagnosis

35
Q

what can help reduce thromboembolism in pts with APS and SLE

A

hyroxychloroquine

36
Q

most common cause of hereditary hypercoagubility are

A

factor V leiden and prothrombin gene mutation

37
Q

what does a hypercoag panal include

A

factor v and prothrombin test
and also protein C and S test
won’t include APS antibody and lupus anticoagulant

38
Q

treatment of APS during pregnancy

A

SC heparin